Zobrazeno 1 - 10
of 326
pro vyhledávání: '"Carbapenem resistant Pseudomonas aeruginosa"'
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 4327-4332 (2024)
Sandip Patil, Xinye Li, Huirong Mai, Ying Wang, Xue Tang, Sixi Liu, Feiqiu Wen Department of Haematology and Oncology, Shenzhen Children’s Hospital, Shenzhen, Guangdong Province, People’s Republic of ChinaCorrespondence: Sixi Liu; Feiqiu Wen, Ema
Externí odkaz:
https://doaj.org/article/80c2a876960b4cc3845ed89ab3ec5dae
Autor:
Andrés Opazo-Capurro, Omar Alejandro Aguilar-Vera, Paulina González-Muñoz, Luis Amsteins-Romero, Monserrat Quiroga, Antonia Encina, Néstor Herrera-Chávez, Mario Quezada-Aguiluz, Alejandro Aguayo-Reyes, Felipe Morales-León, Vijna Illesca, Rodrigo Vera, Fabiola Salgado, Patricio Suazo, Luz María Fuenzalida, Helia Bello-Toledo, Santiago Castillo-Ramírez, Gerardo González-Rocha
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 38, Iss , Pp 205-211 (2024)
Introduction: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a serious threat to public health. Globally, carbapenemases-producing CRPA isolates mainly belong to ‘high-risk’ clones; however, the molecular epidemiology of CRPA isolates circ
Externí odkaz:
https://doaj.org/article/2b4f2d507ca44cb89a957138e5c658b1
Publikováno v:
Asian Journal of Medical Sciences, Vol 15, Iss 8, Pp 79-84 (2024)
Background: Worldwide, the emergence of carbapenem-resistant enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a global concern to public health as they are responsible for several serious infections that lead to elevat
Externí odkaz:
https://doaj.org/article/b8b5c653d2c84490bb5e0473061f29df
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 1357-1365 (2024)
Yingying Shen,1,2,* Junmin Cao,3,* Tonglin Hu,1,2 Xiawan Yang,1,2 Yuechao Zhao,1,2 Yiping Shen,1,2 Baodong Ye,1,2 Yunsong Yu,4 Dijiong Wu1,2 1Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhej
Externí odkaz:
https://doaj.org/article/3cfd6fe075724ad7abab097c3856af66
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The treatment of brain abscess induced by carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a clinical challenge around the world. Apart from novel β-lactam/β-lactamase inhibitors and polymyxins, there are few sufficiently powerful antibiotics
Externí odkaz:
https://doaj.org/article/304ed0db3dcb422c93eb93d227d62535
Autor:
Yili Chen, Guoxiu Xiang, Pingjuan Liu, Xianling Zhou, Penghao Guo, Zhongwen Wu, Juhua Yang, Peisong Chen, Junqi Huang, Kang Liao
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 36, Iss , Pp 276-283 (2024)
ABSTRACT: Objectives: Resistance against ceftazidime-avibactam (CZA) in carbapenem-resistant Pseudomonas aeruginosa (CRPA) is emerging. This study was aimed at detecting the prevalence and molecular characteristics of CZA-resistant CRPA clinical isol
Externí odkaz:
https://doaj.org/article/93f4702d556740d098fe13bbe2750b48
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Carbapenem-resistant Pseudomonas aeruginosa (CRPA) infection has become a major public health concern. The recommendations for monotherapy and combination therapy in the current guidelines lack sufficient evidence to support them.
Externí odkaz:
https://doaj.org/article/c2035137aead46e58a34700fc519f63d
Autor:
Solomon O. Iyam, Sopuruchukwu E. Ogbodo, Ejike R. Okafor, Musa Runde, Alpha O. Gulack, Michael O. Odey, Aniekan E. Owen, Uwem Edet, Innocent Benjamin, Hiter Louis
Publikováno v:
Chemical Physics Impact, Vol 8, Iss , Pp 100466- (2024)
The sobering reality is that numerous infectious diseases can no longer be effectively treated with antibiotics, necessitating immediate attention and action. Therefore, this study explores a thiadiazol derivative for the purpose of elucidating its a
Externí odkaz:
https://doaj.org/article/e7ebd5a031d647e5a15855427d570bd3
Autor:
Russell E. Lewis, Marta Palombo, Erica Diani, Benedetta Secci, Davide Gibellini, Paolo Gaibani
Publikováno v:
Cells, Vol 13, Iss 16, p 1315 (2024)
We investigated the activity of cefiderocol/β-lactamase inhibitor combinations against clinical strains with different susceptibility profiles to cefiderocol to explore the potentiality of antibiotic combinations as a strategy to contain the major p
Externí odkaz:
https://doaj.org/article/0af9bc8691ac48acaea1a559592b899f
Autor:
Mei Zeng, Jun Xia, Zhiyong Zong, Yi Shi, Yuxing Ni, Fupin Hu, Yijian Chen, Chao Zhuo, Bijie Hu, Xiaoju Lv, Jiabin Li, Zhengyin Liu, Jing Zhang, Wenjie Yang, Fan Yang, Qiwen Yang, Hua Zhou, Xin Li, Jianhua Wang, Yimin Li, Jian'an Ren, Baiyi Chen, Dechang Chen, Anhua Wu, Xiangdong Guan, Jieming Qu, Depei Wu, Xiaojun Huang, Haibo Qiu, Yingchun Xu, Yunsong Yu, Minggui Wang
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 56, Iss 4, Pp 653-671 (2023)
The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug-resistant, resulting in limited antimicrobial treatment options and high mortali
Externí odkaz:
https://doaj.org/article/086fe2a85e514e3581f1906b212d7263